Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sertindole Versus Risperidone Safety Outcome Study: a Randomised, Partially-blinded, Parallel-group, Active-controlled, Post-marketing Study

NCT00856583 is registered in ClinicalTrials.gov with H. Lundbeck A/S as lead sponsor.

NCT NCT00856583
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00856583 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sertindole Versus Risperidone Safety Outcome Study: a Randomised, Partially-blinded, Parallel-group, Active-controlled, Post-marketing Study
Lead sponsor
H. Lundbeck A/S
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2002
Completion date
February 29, 2008
Enrollment
9,809 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia